WO2008108262A1 - 免疫調節剤 - Google Patents

免疫調節剤 Download PDF

Info

Publication number
WO2008108262A1
WO2008108262A1 PCT/JP2008/053489 JP2008053489W WO2008108262A1 WO 2008108262 A1 WO2008108262 A1 WO 2008108262A1 JP 2008053489 W JP2008053489 W JP 2008053489W WO 2008108262 A1 WO2008108262 A1 WO 2008108262A1
Authority
WO
WIPO (PCT)
Prior art keywords
ganglioside
agent
immunomodulating agent
beverage
food
Prior art date
Application number
PCT/JP2008/053489
Other languages
English (en)
French (fr)
Inventor
Atsushi Serizawa
Fumihiko Sakai
Yutaka Miura
Original Assignee
Snow Brand Milk Products Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co., Ltd. filed Critical Snow Brand Milk Products Co., Ltd.
Priority to CN2008800069122A priority Critical patent/CN101622267B/zh
Publication of WO2008108262A1 publication Critical patent/WO2008108262A1/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/14—Organic oxygen compounds
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/14—Organic oxygen compounds
    • A21D2/16—Fatty acid esters
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/20—Animal feeding-stuffs from material of animal origin
    • A23K10/26—Animal feeding-stuffs from material of animal origin from waste material, e.g. feathers, bones or skin
    • A23K10/28—Animal feeding-stuffs from material of animal origin from waste material, e.g. feathers, bones or skin from waste dairy products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87—Re-use of by-products of food processing for fodder production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)

Abstract

　本発明は、ガングリオシドＧＤ３の免疫機能に関する新規の作用機序及びそれを利用した医薬用途を見出し、種々の免疫疾患の予防剤または治療剤として有効な医薬並びにそれを配合した飲食品及び飼料を提供することを課題とする。ガングリオシドＧＤ３を有効成分とする免疫機能調節剤。ガングリオシドＧＤ３は乳由来であることが好ましい。前記免疫機能調節剤を飲食品または飼料に配合する。
PCT/JP2008/053489 2007-03-02 2008-02-28 免疫調節剤 WO2008108262A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008800069122A CN101622267B (zh) 2007-03-02 2008-02-28 免疫调节剂

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007052519A JP2008214241A (ja) 2007-03-02 2007-03-02 免疫調節剤
JP2007-052519 2007-03-02

Publications (1)

Publication Number Publication Date
WO2008108262A1 true WO2008108262A1 (ja) 2008-09-12

Family

ID=39738145

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/053489 WO2008108262A1 (ja) 2007-03-02 2008-02-28 免疫調節剤

Country Status (4)

Country Link
JP (1) JP2008214241A (ja)
KR (1) KR20090115860A (ja)
CN (1) CN101622267B (ja)
WO (1) WO2008108262A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6282446B2 (ja) * 2013-11-14 2018-02-21 雪印メグミルク株式会社 静菌または抗菌剤及びその製造方法
EP3384928A4 (en) 2015-11-30 2019-06-26 The Noguchi Institute GM3-SPONSORED INFLAMMATORY INHIBITOR AND PRODUCTION INHIBITOR OF INFLAMMATORY CYTOKINES

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005844A1 (de) * 1994-08-24 1996-02-29 Milupa Gmbh & Co. Kg Allergieprotektive formelnahrung mit gangliosiden
JP2002504101A (ja) * 1997-06-12 2002-02-05 シーエスエル、リミテッド ガングリオシド免疫刺激複合体およびその使用
JP2004531469A (ja) * 2000-12-08 2004-10-14 チルドレンズ メモリアル ホスピタル 皮膚疾病の治療に使用するガングリオシドを含む組成物
WO2005107769A1 (ja) * 2004-05-07 2005-11-17 Snow Brand Milk Products Co., Ltd. 口腔内細菌叢改善剤、抗菌剤及び生育促進剤
JP2007131550A (ja) * 2005-11-08 2007-05-31 Snow Brand Milk Prod Co Ltd 免疫機能調節剤

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005844A1 (de) * 1994-08-24 1996-02-29 Milupa Gmbh & Co. Kg Allergieprotektive formelnahrung mit gangliosiden
JP2002504101A (ja) * 1997-06-12 2002-02-05 シーエスエル、リミテッド ガングリオシド免疫刺激複合体およびその使用
JP2004531469A (ja) * 2000-12-08 2004-10-14 チルドレンズ メモリアル ホスピタル 皮膚疾病の治療に使用するガングリオシドを含む組成物
WO2005107769A1 (ja) * 2004-05-07 2005-11-17 Snow Brand Milk Products Co., Ltd. 口腔内細菌叢改善剤、抗菌剤及び生育促進剤
JP2007131550A (ja) * 2005-11-08 2007-05-31 Snow Brand Milk Prod Co Ltd 免疫機能調節剤

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DOZMOROV I.M. ET AL.: "Nanomolar concentrations of gangliosides stimulate primary humoral response", BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL, vol. 42, no. 1, 1997, pages 57 - 63 *
DYATLOVITSKAYA E.V. ET AL.: "Immunomodulatory effects of human placenta gangliosides", BIOMEDICAL SCIENCE, vol. 1, no. 4, 1990, pages 397 - 400 *
HOON D.S.V.B. ET AL.: "Gangliosides from human melanoma immunomodulate response of T cells to interleukin-2", CELLULAR IMMUNOLOGY, vol. 111, no. 2, 1988, pages 410 - 419, XP024001583, DOI: doi:10.1016/0008-8749(88)90104-9 *
MORIOKA N. ET AL.: "Gangliosides inhibit the proliferation of human T cells stimulated with interleuin 4 or interleukin 2", SKIN RESEARCH, vol. 34, no. 12, 1992, pages 223 - 229 *
ZIEGLER-HEITBROCK H.W. ET AL.: "Gangliosides suppress tumor necrosis factor production in human monocytes", THE JOURNAL OF IMMUNOLOGY, vol. 148, no. 6, 1992, pages 1753 - 1758 *

Also Published As

Publication number Publication date
JP2008214241A (ja) 2008-09-18
KR20090115860A (ko) 2009-11-09
CN101622267A (zh) 2010-01-06
CN101622267B (zh) 2013-01-30

Similar Documents

Publication Publication Date Title
WO2008143182A1 (ja) 甘草ポリフェノールを含有する組成物
JP2009203244A5 (ja)
FR2953135B1 (fr) Extrait de graines d'acacia macrostachya et compositions cosmetiques, pharmaceutiques, dermatologiques, nutraceutiques ou alimentaires le comprenant
RS20070305A (en) Formulations in the form of foam as modificators of immune response foamlike formulations as immunity modificators
EP2102225A4 (en) ALPHA-GALACTOSYLCERAMIDE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION OF IMMUNOLOGICAL ADJUVANT CONTAINING THESE COMPOUNDS AS ACTIVE INGREDIENT
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
IL213019A (en) Derivatives 1-Azo-3-Terroyl-Azoline, Pharmaceutical Preparations Containing and Using Them
WO2010000877A3 (en) Formulation with irritation reducing action comprising bisabolol and [6]-paradol
WO2011043631A3 (ko) 호장근 추출물, 이의 분획물 또는 스틸벤계 화합물을 포함하는 감기의 예방 및 치료용 약학 조성물
HK1178792A1 (en) Dried plant tissue and plant tissue extract for ameliorating central nervous system degenerative diseases accompanied by learning memory disorders, movement disorders and the like, and pharmaceutical agent and food or beverage each comprising the dried plant tissue and the plant tissue extract
WO2008006839A3 (en) Combinations of flibanserin with caffeine, process for their preparation and use thereof as medicaments
EP2131850A4 (en) ASTER KORAIENSIS EXTRACTS AND PHARMACEUTICAL COMPOSITION AND FUNCTIONAL FOOD CONTAINING SAME
PL2173195T3 (pl) Biomasa wzbogacona w cynk, sposób jej wytwarzania oraz zawierające ją produkty probiotyczne, kosmetyczne, dietetyczne i nutraceutyczne
WO2011059292A3 (ko) 피부세포증식 촉진, 항산화 및 항알러지 효과가 우수한 알로에 베라 새순 농축물 또는 추출물
WO2010021607A3 (en) Pharmaceutical formulation
WO2012091440A3 (en) Composition for improvement, treatment and prevention of gastrointestinal motility disorders
IL217293A (en) Annotations of 9,8,7,6-tetrahydropyrimido {{a-2,1 pyramidine-4-one)
BRPI0811347A2 (pt) "extrato herbáceo medicinal dotado de efeito antiobesidade"
WO2005076761A3 (en) Composition for preenting a cold
WO2006109194A3 (en) Chromium-fatty acid compounds and methods of making and using thereof
WO2013019091A3 (en) A COMPOUND FOR INHIBITING 11β-HYDROXY STEROID DEHYDROGENASE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
EP2019098A4 (en) SUPPRESSOR OF THE EXPRESSION OF MCP-1 AND RELYING MEDICAMENT FOR INFLAMMATORY DISEASE, PHARMACEUTICAL, COMPLEMENTARY AGENT, FOOD, BEVERAGE OR FOOD SUPPLEMENT USING THE SUPPRESSOR
EP2050442A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF BONE DISORDERS, FUNCTIONAL FOOD OR HEALTH MEASURES CONTAINING THIS COMPOSITION AND PHARMACEUTICAL PREPARATION CONTAINING THE COMPOSITION AS AN ACTIVE SUBSTANCE
WO2008126367A1 (ja) 精神安定剤および機能性食品
IL187575A (en) Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880006912.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08720984

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 1020097018241

Country of ref document: KR

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08720984

Country of ref document: EP

Kind code of ref document: A1